Optimisation and pre-clinical development of a KIFC1-PROTAC as a triple-negative breast cancer therapeutic - Research Portal | Lancaster University

Home > Research > Projects > Optimisation and pre-clinical development of a ...

View graph of relations

Optimisation and pre-clinical development of a KIFC1-PROTAC as a triple-negative breast cancer therapeutic

Project: Research

Status	Active
Effective start/end date	10/06/24 → 10/06/27

Fielding, Andrew (Principal Investigator)